A recent cross-sectional study conducted by Jennifer Flythe, MD, MPH, and colleagues at the University of North Carolina Kidney Center revealed alarming trends in the prescription of QT-prolonging medications with known torsades de pointes (TdP) risk to older dialysis-dependent patients. The study, published in JAMA Network Open, focused on Medicare patients receiving in-center hemodialysis and
President Joe Biden recently unveiled an updated policy aimed at protecting U.S. critical infrastructure sectors such as energy and financial services from foreign cyberattacks, particularly those originating from China. This new policy, a revision of the Obama-era Presidential Policy Directive (PPD-21) issued in 2013, reflects the evolving threat landscape driven by technological advancements and strategic
Recently, a federal judge in New Jersey made a significant ruling regarding Johnson & Johnson’s and Bristol Myers Squibb’s legal challenges to the Biden administration’s Medicare drug-price negotiations. The judge rejected their claims, stating that the program is constitutional. This decision marks a victory for the White House in its ongoing legal dispute with multiple